Wealthspring Capital’s Translational Development Acquisition Corp TDAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-204,690
Closed -$2.16M 229
2026
Q1
$2.16M Sell
204,690
-2,540
-1% -$26.8K 0.51% 73
2025
Q4
$2.17M Hold
207,230
0.51% 73
2025
Q3
$2.14M Sell
207,230
-2,770
-1% -$28.6K 0.51% 63
2025
Q2
$2.16M Buy
+210,000
New +$2.13M 0.57% 56

Other funds holding TDAC

Wealthspring Capital's TDAC Position: Q2 2026 in Review

Wealthspring Capital sold out of Translational Development Acquisition Corp (TDAC) in Q2 2026, closing a stake of 204,690 shares — an estimated $2.16M sold.

Wealthspring Capital first reported a position in TDAC in Q2 2025 and held it in 4 quarters. The position peaked at $2.17M in Q4 2025. 29 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

  • Wealthspring Capital reported no remaining Translational Development Acquisition Corp position as of Q2 2026 after selling out during the quarter.
  • Wealthspring Capital sold 204,690 Translational Development Acquisition Corp shares in Q2 2026, an estimated $2.16M.
  • Wealthspring Capital first reported a position in Translational Development Acquisition Corp in Q2 2025 and held it in 4 quarters.
  • Wealthspring Capital's Translational Development Acquisition Corp position peaked at $2.17M in Q4 2025.
  • 29 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on Wealthspring Capital's 13F filing for Q2 2026, filed 15 Jul 2026.